<DOC>
	<DOCNO>NCT01046929</DOCNO>
	<brief_summary>Limonene major component essential oil citrus fruit . It demonstrate promise breast cancer preventive therapeutic effect preclinical model system . This early phase clinical study evaluate distribution limonene breast tissue associate biological activity 2 6 week limonene dose woman recent diagnosis early stage breast cancer . This study help evaluate potential develop limonene breast cancer preventive agent .</brief_summary>
	<brief_title>Limonene Study Women With Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Women 18 year age old Women elect undergo excision surgery early stage breast cancer A minimum 2 week enrollment definitive surgery Underwent core needle biopsy breast cancer diagnosis No clinical evidence metastatic breast cancer ECOG performance status 01 Participants must normal organ marrow function Women childbearing potential must agree use adequate contraception Ability understand willingness sign write informed consent document Concurrent chemotherapy radiation therapy Use selective estrogen receptor modifier aromatase inhibitor within past 3 month concurrently History malignancy within past 5 year exclude nonmelanoma skin cancer cancer confine organ removal treatment Participated another clinical intervention trial within past 3 month Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement Pregnant breastfeed woman Use dietary supplement contain large amount dlimonene ( Heartburn Free ROH10 CoQ dlimonene ) within past 3 month</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>limonene</keyword>
	<keyword>breast cancer</keyword>
	<keyword>cancer prevention</keyword>
</DOC>